TRACON Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference
Mar 29, 2017 20:09 pm UTC| Business
SAN DIEGO, March 29, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
Cartesian Reports Fourth Quarter and Full Year 2016 Financial Results
Mar 29, 2017 20:10 pm UTC| Business
OVERLAND PARK, Kan., March 29, 2017 -- Cartesian, Inc. (NASDAQ:CRTN), a specialist provider of consulting services and managed solutions to the global communications, technology and digital media industries, reported...
TRACON Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference
Mar 29, 2017 20:09 pm UTC| Business
SAN DIEGO, March 29, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
TRACON Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference
Mar 29, 2017 20:09 pm UTC| Business
SAN DIEGO, March 29, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
Cara Therapeutics Announces Proposed Offering of Common Stock
Mar 29, 2017 20:09 pm UTC| Business
STAMFORD, Conn., March 29, 2017 -- Cara Therapeutics, Inc.(Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...
TRACON Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference
Mar 29, 2017 20:09 pm UTC| Business
SAN DIEGO, March 29, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
Cara Therapeutics Announces Proposed Offering of Common Stock
Mar 29, 2017 20:09 pm UTC| Business
STAMFORD, Conn., March 29, 2017 -- Cara Therapeutics, Inc.(Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...
US–India Trade Talks Race Toward USD 500 Billion Goal